ANew Medical shares are trading higher after the company announced the grant of US Patent no. 12,036,268 for Klotho gene therapy targeting neurodegenerative diseases.
Portfolio Pulse from Benzinga Newsdesk
ANew Medical shares are trading higher following the announcement of a new US patent for their Klotho gene therapy, which targets neurodegenerative diseases.
August 15, 2024 | 2:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ANew Medical shares are trading higher after the company announced the grant of US Patent no. 12,036,268 for Klotho gene therapy targeting neurodegenerative diseases.
The grant of a new US patent for Klotho gene therapy is a significant milestone for ANew Medical, likely boosting investor confidence and driving the stock price higher in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100